Expression, genomic patterns predict sarcoma progression

In synovial sarcoma, metastasis development is linked to chromosome complexity.

PET tracer identifies which liposarcoma tumors may respond to chemotherapy

Researchers have identified a group of liposarcoma tumors that can be imaged by positron emission tomography scans using a tracer substance known as FAC.

Annual report highlights 2012 cancer advances

The American Society of Clinical Oncology has released a nearly 100-page report detailing the year's most significant developments in cancer.

Regorafenib prolongs survival in face of GI cancers

Persons with metastatic colorectal cancer or gastrointestinal stromal tumors may garner some survival benefit from regorafenib after standard treatments have failed.

Possible new treatment for Ewing sarcoma

Discovery of a new drug with high potential to treat Ewing sarcoma and of the previously unknown mechanism behind the disease came hand-in-hand.

Pazopanib (Votrient)

Pazopanib is a tyrosine kinase inhibitor indicated for renal cell carcinoma and advanced soft tissue sarcoma in patients who have received prior chemotherapy.

Well-known antifungal drug shows promise against cancer

Thiabendazole, an antifungal drug in clinical use for 40 years, inhibits angiogenesis, slows tumor growth, and reduces vascular density of tumors.

Vincristine (Oncovin, Vincasar)

Vincristine is a vinca alkaloid indicated for the treatment of certain cancers, and may also be used in some combination therapies.

Clinical Trial: Pomalidomide for Kaposi Sarcoma in People With or Without HIV

Clinical Trial: Preoperative Proton Radiotherapy for Retroperitoneal Sarcoma (SA03)

Clinical Trial: Treatment of Patients With RAD001 Who Have Progressive Sarcoma

Clinical Trial: A Scandinavian Sarcoma Group Protocol for Patients With High-risk Soft Tissue Sarcoma of the Extremities and Trunk Wall (SSGXX)

Clinical Trial: Sorafenib and Dacarbazine in Soft Tissue Sarcoma